The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(2-amino-6-phenylpyrimidin-4-yl)phenyl morpholine-4-carboxylate ID: ALA3754167
PubChem CID: 127036830
Max Phase: Preclinical
Molecular Formula: C21H20N4O3
Molecular Weight: 376.42
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(-c2ccccc2)cc(-c2cccc(OC(=O)N3CCOCC3)c2)n1
Standard InChI: InChI=1S/C21H20N4O3/c22-20-23-18(15-5-2-1-3-6-15)14-19(24-20)16-7-4-8-17(13-16)28-21(26)25-9-11-27-12-10-25/h1-8,13-14H,9-12H2,(H2,22,23,24)
Standard InChI Key: VIBAFZDZRHJJRN-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8934 -5.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1924 -6.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4915 -5.2571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4915 -3.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1925 -3.0070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8969 -9.7600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8945 -8.2599 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.1924 -7.5078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4926 -8.2559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4949 -9.7559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1971 -10.5079 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7958 -10.5042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0950 -9.7543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3940 -10.5043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3939 -12.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0949 -12.7543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7959 -12.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8586 -10.3616 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
1 6 1 0
7 8 2 0
7 9 1 0
1 7 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
10 15 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
16 21 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
22 27 2 0
20 22 1 0
16 28 1 0
12 18 1 0
9 10 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.42Molecular Weight (Monoisotopic): 376.1535AlogP: 3.22#Rotatable Bonds: 3Polar Surface Area: 90.57Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 3.83CX LogP: 3.47CX LogD: 3.47Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -1.16
References 1. Robinson SJ, Petzer JP, Rousseau AL, Terre'Blanche G, Petzer A, Lourens AC.. (2016) Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists., 26 (3): [PMID:26776359 ] [10.1016/j.bmcl.2016.01.004 ] 2. Saini A, Patel R, Gaba S, Singh G, Gupta GD, Monga V.. (2022) Adenosine receptor antagonists: Recent advances and therapeutic perspective., 227 [PMID:34695776 ] [10.1016/j.ejmech.2021.113907 ]